ASIA-PACIFIC BIOSURGERY MARKET 2021-2028

Lifesciences | Medical Devices & Consumables

ASIA-PACIFIC BIOSURGERY MARKET 2021-2028

Market by Product, Application, Source Type, and Country | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As stated in Triton’s research report, the Asia-Pacific biosurgery market is projected to grow at 7.56% of CAGR during the period 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries considered in this market include:

•        India

•        China

•        Japan

•        Australia & New Zealand

•        South Korea

•        ASEAN countries

•        Rest of Asia-Pacific

The studied market’s growth in the region is supported by various factors, such as the rising occurrence of chronic diseases, the increase in surgical procedures, and the development of new products. Furthermore, due to the growth in lifestyle diseases and the surge in geriatric populations, the demand for biosurgery products has increased across the major nations, including China and Japan. Hence, these factors are largely supporting the growth of the biosurgery market over the forecast period.

China, for instance, has a well-developed healthcare industry across the region. The rising number of patients suffering from chronic diseases, along with the growing number of surgical procedures, are anticipated to supplement the studied market’s progress. As per estimates, in recent years, the number of cancer patients has surged across the country, resulting in multiple patients opting for surgeries to remove the tumor. Other than this, the surge in cardiovascular diseases has augmented the demand for biosurgery products, thereby widening the scope and growth of the Chinese biosurgery market over the estimated period.

Likewise, the number of aging populations is anticipated to proliferate across Japan by 2050. This rise will increase the prevalence of chronic conditions among geriatric people, enhancing the demand for biosurgery products. Thus, as mentioned above, these factors are likely to boost the biosurgery market’s growth.

CSL Limited is involved in offering products used to treat and prevent rare medical conditions. It majorly operates through its human health segment. Besides, the company’s products are used for various applications, including hematology, cardiovascular, metabolic, transplant, and respiratory. Moreover, it offers a wide range of products to the Australian government. CSL has business operations across various countries, with headquarters located in Melbourne, Australia. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. ASIA-PACIFIC BIOSURGERY MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON BIOSURGERY MARKET

2.2. TRENDS IN BIOSURGERY TECHNOLOGY

2.3. KEY INSIGHTS

2.4. PORTER’S FIVE FORCES MODEL

2.4.1. THREAT OF NEW ENTRANTS

2.4.2. THREAT OF SUBSTITUTE PRODUCTS

2.4.3. BARGAINING POWER OF BUYERS

2.4.4. BARGAINING POWER OF SUPPLIERS

2.4.5. COMPETITIVE RIVALRY

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. KEY BUYING OUTLOOK

2.8. KEY MARKET STRATEGIES

2.8.1. CONTRACTS AND PARTNERSHIPS

2.8.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

2.8.3. ACQUISITIONS & MERGERS

2.8.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS

2.9. MARKET DRIVERS

2.9.1. GROWING AGING POPULATION

2.9.2. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN HEALTHCARE FACILITIES

2.9.3. SURGE IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS

2.9.4. PREVALENCE OF SPINAL FUSION AND JOINT RECONSTRUCTION

2.9.5. STRONG FOCUS ON RESEARCH AND DEVELOPMENT

2.10. MARKET CHALLENGES

2.10.1. HIGH COST OF SURGERIES

2.10.2. COMPLICATIONS RELATED TO IMMUNE RESPONSE

2.10.3. USAGE OF MINIMALLY INVASIVE SURGERIES

2.11. MARKET OPPORTUNITIES

2.11.1. RESEARCH AND INVESTMENTS IN BIOENGINEERING

2.11.2. DEVELOPMENT OF POLICIES FOR REIMBURSEMENT AND COMPENSATION

3. ASIA-PACIFIC BIOSURGERY MARKET - BY PRODUCT

3.1. HEMOSTATIC AGENTS

3.2. BONE-GRAFT SUBSTITUTES

3.2.1. SYNTHETIC GRAFT EXTENDERS

3.2.2. DEMINERALIZED BONE MATRIX

3.2.3. BONE MORPHOGENETIC PROTEINS

3.2.4. CELL-BASED MATRICES

3.3. SURGICAL SEALING AGENTS

3.3.1. NATURAL

3.3.2. SYNTHETIC

3.4. SOFT-TISSUE MANAGEMENT

3.4.1. SYNTHETIC MESH/PATCH

3.4.2. NATURAL MESH/PATCH

3.5. ANTI-ADHESIVE AGENTS

3.6. STAPLE LINE REINFORCEMENT

4. ASIA-PACIFIC BIOSURGERY MARKET - BY APPLICATION

4.1. ORTHOPEDIC SURGERY

4.2. CARDIO AND THORACIC SURGERY

4.3. NEURO AND SPINE SURGERY

4.4. GENERAL SURGERY

4.5. OTHER APPLICATIONS

5. ASIA-PACIFIC BIOSURGERY MARKET – BY SOURCE TYPE

5.1. NATURAL

5.2. SYNTHETIC

6. ASIA-PACIFIC BIOSURGERY MARKET – COUNTRY OUTLOOK

6.1. COUNTRY ANALYSIS

6.1.1. CHINA

6.1.2. JAPAN

6.1.3. INDIA

6.1.4. AUSTRALIA & NEW ZEALAND

6.1.5. SOUTH KOREA

6.1.6. ASEAN COUNTRIES

6.1.7. REST OF ASIA-PACIFIC

7. COMPETITIVE LANDSCAPE

7.1. BAXTER INTERNATIONAL INC

7.2. BECTON, DICKINSON AND COMPANY

7.3. B BRAUN MELSUNGEN AG

7.4. CSL LIMITED

7.5. ETHICON INC (JOHNSON & JOHNSON)

7.6. INTEGRA LIFESCIENCES HOLDINGS CORPORATION

7.7. MEDTRONIC PLC

7.8. RTI SURGICAL

7.9. SANOFI

7.10. SMITH & NEPHEW PLC

7.11. STRYKER CORPORATION

7.12. WRIGHT MEDICAL GROUP NV

7.13. ZIMMER BIOMET HOLDINGS INC

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1. OBJECTIVES OF STUDY

8.1.2. SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1. PRIMARY DATA SOURCES

8.2.2. SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1. EVALUATION OF PROPOSED MARKET

8.3.2. IDENTIFICATION OF DATA SOURCES

8.3.3. ASSESSMENT OF MARKET DETERMINANTS

8.3.4. DATA COLLECTION

8.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       ASIA-PACIFIC BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR SCORECARD

TABLE 3:       CONTRACTS AND PARTNERSHIPS

TABLE 4:       BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

TABLE 5:       ACQUISITIONS & MERGERS

TABLE 6:       NEW PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 7:       ASIA-PACIFIC BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 8:       ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 9:       ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 10:     ASIA-PACIFIC SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 11:     ASIA-PACIFIC BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 12:     ASIA-PACIFIC BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)

TABLE 13:     ASIA-PACIFIC BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     ASIA-PACIFIC BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     ASIA-PACIFIC BIOSURGERY MARKET, BY PRODUCT, 2020 & 2028 (IN %)

FIGURE 3:     ASIA-PACIFIC BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)

FIGURE 4:     ASIA-PACIFIC BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 5:     ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $ MILLION)

FIGURE 6:     ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $ MILLION)

FIGURE 7:     ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $ MILLION)

FIGURE 8:     ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)

FIGURE 9:     ASIA-PACIFIC BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)

FIGURE 10:  ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)

FIGURE 11:  ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)

FIGURE 12:  ASIA-PACIFIC BIOSURGERY MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)

FIGURE 13:  ASIA-PACIFIC SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION)

FIGURE 14:  ASIA-PACIFIC SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)

FIGURE 15:  ASIA-PACIFIC BIOSURGERY MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)

FIGURE 16:  ASIA-PACIFIC BIOSURGERY MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)

FIGURE 17:  ASIA-PACIFIC BIOSURGERY MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 18:  ASIA-PACIFIC BIOSURGERY MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 19:  ASIA-PACIFIC BIOSURGERY MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 20:  ASIA-PACIFIC BIOSURGERY MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 21:  ASIA-PACIFIC BIOSURGERY MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 22:  ASIA-PACIFIC BIOSURGERY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 23:  ASIA-PACIFIC BIOSURGERY MARKET, BY SOURCE TYPE, 2020 & 2028 (IN %)

FIGURE 24:  ASIA-PACIFIC BIOSURGERY MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)

FIGURE 25:  ASIA-PACIFIC BIOSURGERY MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)

FIGURE 26:  CHINA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 27:  JAPAN BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 28:  INDIA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 29:  AUSTRALIA & NEW ZEALAND BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 30:  SOUTH KOREA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 31:  ASEAN COUNTRIES BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

FIGURE 32:  REST OF ASIA-PACIFIC BIOSURGERY MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;